APA

de Gramont A., Brienza S., Marty M., Lévi F., Ducreux M., François E., Gamelin E., Bleiberg H., Bleuzen P., Simon J. & Cvitkovic E. (20011011). Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU)+/-folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patients. : European journal of cancer (Oxford, England : 1990).

Chicago

de Gramont A, Brienza S, Marty M, Lévi F, Ducreux M, François E, Gamelin E, Bleiberg H, Bleuzen P, Simon J and Cvitkovic E. 20011011. Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU)+/-folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patients. : European journal of cancer (Oxford, England : 1990).

Harvard

de Gramont A., Brienza S., Marty M., Lévi F., Ducreux M., François E., Gamelin E., Bleiberg H., Bleuzen P., Simon J. and Cvitkovic E. (20011011). Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU)+/-folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patients. : European journal of cancer (Oxford, England : 1990).

MLA

de Gramont A, Brienza S, Marty M, Lévi F, Ducreux M, François E, Gamelin E, Bleiberg H, Bleuzen P, Simon J and Cvitkovic E. Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU)+/-folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patients. : European journal of cancer (Oxford, England : 1990). 20011011.